Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Cipla Ltd

NSE: CIPLA · BSE: 500087 · Pharmaceuticals & Biotechnology · 44 announcements

Share price
₹1,340.20
Market cap
₹1,08,271 Cr
Revenue (annual)
₹28,163 Cr
Net profit (annual)
₹3,879 Cr
P/E (TTM)
32.1×Sector 47.4×
Promoter holding
29.21%+0.00% QoQ
FII holding
20.20%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:42 IST BSE
Partnership

Cipla Partnership

Cipla signed an exclusive licensing and supply agreement with SBP Group’s CTTQ for the drug Rolditamig Deuderuxtecan. This collaboration aims to accelerate therapy access in licensed markets.